140 related articles for article (PubMed ID: 26106586)
1. Hedgehog Inhibitors in Rhabdomyosarcoma: A Comparison of Four Compounds and Responsiveness of Four Cell Lines.
Ridzewski R; Rettberg D; Dittmann K; Cuvelier N; Fulda S; Hahn H
Front Oncol; 2015; 5():130. PubMed ID: 26106586
[TBL] [Abstract][Full Text] [Related]
2. Different Response of
Geyer N; Ridzewski R; Bauer J; Kuzyakova M; Dittmann K; Dullin C; Rosenberger A; Schildhaus HU; Uhmann A; Fulda S; Hahn H
Front Oncol; 2018; 8():396. PubMed ID: 30319965
[TBL] [Abstract][Full Text] [Related]
3. Reduction of human embryonal rhabdomyosarcoma tumor growth by inhibition of the hedgehog signaling pathway.
Tostar U; Toftgård R; Zaphiropoulos PG; Shimokawa T
Genes Cancer; 2010 Sep; 1(9):941-51. PubMed ID: 21779473
[TBL] [Abstract][Full Text] [Related]
4. Novel-smoothened inhibitors for therapeutic targeting of naïve and drug-resistant hedgehog pathway-driven cancers.
Li QR; Zhao H; Zhang XS; Lang H; Yu K
Acta Pharmacol Sin; 2019 Feb; 40(2):257-267. PubMed ID: 29777201
[TBL] [Abstract][Full Text] [Related]
5. SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer.
Della Corte CM; Bellevicine C; Vicidomini G; Vitagliano D; Malapelle U; Accardo M; Fabozzi A; Fiorelli A; Fasano M; Papaccio F; Martinelli E; Troiani T; Troncone G; Santini M; Bianco R; Ciardiello F; Morgillo F
Clin Cancer Res; 2015 Oct; 21(20):4686-97. PubMed ID: 26124204
[TBL] [Abstract][Full Text] [Related]
6. Discovery, molecular and pharmacological characterization of GSA-10, a novel small-molecule positive modulator of Smoothened.
Gorojankina T; Hoch L; Faure H; Roudaut H; Traiffort E; Schoenfelder A; Girard N; Mann A; Manetti F; Solinas A; Petricci E; Taddei M; Ruat M
Mol Pharmacol; 2013 May; 83(5):1020-9. PubMed ID: 23448715
[TBL] [Abstract][Full Text] [Related]
7. Repurposing of posaconazole as a hedgehog/SMO signaling inhibitor for embryonal rhabdomyosarcoma therapy.
Sun J; Lin W; Li C; Ueki H; Xue R; Sadahira T; Hu H; Wada K; Li N; Liu C; Araki M; Xu A; Huang P
Am J Cancer Res; 2021; 11(9):4528-4540. PubMed ID: 34659903
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice.
van Gaal JC; Roeffen MH; Flucke UE; van der Laak JA; van der Heijden G; de Bont ES; Suurmeijer AJ; Versleijen-Jonkers YM; van der Graaf WT
Eur J Cancer; 2013 Nov; 49(16):3462-70. PubMed ID: 23867124
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcoma.
Graab U; Hahn H; Fulda S
Oncotarget; 2015 Apr; 6(11):8722-35. PubMed ID: 25749378
[TBL] [Abstract][Full Text] [Related]
10. Hedgehog signal inhibitors suppress the invasion of human rhabdomyosarcoma cells.
Oue T; Uehara S; Yamanaka H; Nomura M; Usui N
Pediatr Surg Int; 2013 Nov; 29(11):1153-8. PubMed ID: 23989521
[TBL] [Abstract][Full Text] [Related]
11. Small molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistance.
Dijkgraaf GJ; Alicke B; Weinmann L; Januario T; West K; Modrusan Z; Burdick D; Goldsmith R; Robarge K; Sutherlin D; Scales SJ; Gould SE; Yauch RL; de Sauvage FJ
Cancer Res; 2011 Jan; 71(2):435-44. PubMed ID: 21123452
[TBL] [Abstract][Full Text] [Related]
12. SMO Inhibition Modulates Cellular Plasticity and Invasiveness in Colorectal Cancer.
Magistri P; Battistelli C; Strippoli R; Petrucciani N; Pellinen T; Rossi L; Mangogna L; Aurello P; D'Angelo F; Tripodi M; Ramacciato G; Nigri G
Front Pharmacol; 2017; 8():956. PubMed ID: 29456503
[No Abstract] [Full Text] [Related]
13. Epigallocatechin Gallate Inhibits Cell Growth and Hedgehog Signalling in Human Rhabdomyosarcoma Cell Lines.
Mayer BFB; Stagno MJ; Fuchs J; Warmann SW; Schmid E
Anticancer Res; 2023 Mar; 43(3):1025-1030. PubMed ID: 36854509
[TBL] [Abstract][Full Text] [Related]
14. GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis.
Srivastava RK; Kaylani SZ; Edrees N; Li C; Talwelkar SS; Xu J; Palle K; Pressey JG; Athar M
Oncotarget; 2014 Dec; 5(23):12151-65. PubMed ID: 25432075
[TBL] [Abstract][Full Text] [Related]
15. Calcitriol inhibits hedgehog signaling and induces vitamin d receptor signaling and differentiation in the patched mouse model of embryonal rhabdomyosarcoma.
Uhmann A; Niemann H; Lammering B; Henkel C; Heß I; Rosenberger A; Dullin C; Schraepler A; Schulz-Schaeffer W; Hahn H
Sarcoma; 2012; 2012():357040. PubMed ID: 22550417
[TBL] [Abstract][Full Text] [Related]
16. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines.
Onisto M; Slongo ML; Gregnanin L; Gastaldi T; Carli M; Rosolen A
Int J Oncol; 2005 Sep; 27(3):791-8. PubMed ID: 16077930
[TBL] [Abstract][Full Text] [Related]
17. Aberrant GLI1 Activation in DNA Damage Response, Carcinogenesis and Chemoresistance.
Palle K; Mani C; Tripathi K; Athar M
Cancers (Basel); 2015 Nov; 7(4):2330-51. PubMed ID: 26633513
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of the Hedgehog pathway prevents human rhabdomyosarcoma cell growth.
Kawabata N; Ijiri K; Ishidou Y; Yamamoto T; Nagao H; Nagano S; Maeda S; Komiya S; Setoguchi T
Int J Oncol; 2011 Oct; 39(4):899-906. PubMed ID: 21674124
[TBL] [Abstract][Full Text] [Related]
19. Hedgehog signal inhibitor forskolin suppresses cell proliferation and tumor growth of human rhabdomyosarcoma xenograft.
Yamanaka H; Oue T; Uehara S; Fukuzawa M
J Pediatr Surg; 2011 Feb; 46(2):320-5. PubMed ID: 21292081
[TBL] [Abstract][Full Text] [Related]
20. Exogenous hedgehog antagonist delays but does not prevent fracture healing in young mice.
Liu X; McKenzie JA; Maschhoff CW; Gardner MJ; Silva MJ
Bone; 2017 Oct; 103():241-251. PubMed ID: 28734986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
